Efficacy of Immediate Switching from Bicalutamide to Flutamide as Second-Line Combined Androgen Blockade

We determined whether prostate specific antigen (PSA) would decrease with immediate antiandrogen switching from bicalutamide (BCL) to flutamide (FLT) in patients receiving combined androgen blockade for advanced prostate cancer. From 2002 to 2006, 20 patients who showed PSA failure after first-line...

詳細記述

保存先:
書誌詳細
出版年:Biomed Res Int
主要な著者: Yokomizo, Yumiko, Kawahara, Takashi, Miyoshi, Yasuhide, Otani, Masako, Yamanaka, Shoji, Teranishi, Jun-ichi, Noguchi, Kazumi, Yao, Masahiro, Uemura, Hiroji
フォーマット: Artigo
言語:Inglês
出版事項: Hindawi Publishing Corporation 2016
主題:
Clinical Study
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4963562/
https://ncbi.nlm.nih.gov/pubmed/27493956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/4083183
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料